Healthcare Providers and Services
Company Overview of Joslin Diabetes Center, Inc.
Joslin Diabetes Center, Inc. operates a diabetes treatment, research, and education institution. It offers research programs for preventing and curing type 1 and type 2 diabetes and their long-term complications. The company also provides diabetes care services for adult and pediatric patients. In addition, it develops and markets programs, products, and services for the availability of the company’s knowledge and expertise to people with diabetes and the clinicians caring for them. Joslin Diabetes Center, Inc. was founded in 1898 and is headquartered in Boston, Massachusetts.
One Joslin Place
Boston, MA 02215
Founded in 1898
Key Executives for Joslin Diabetes Center, Inc.
Chief Executive Officer and President
Chief Scientific Officer, Senior Vice President and Trustee
Senior Vice President of Medical Affairs
Senior Vice President of Strategic Initiatives
Compensation as of Fiscal Year 2015.
Joslin Diabetes Center, Inc. Key Developments
Joslin Diabetes Center Appoints Peter Amenta as New President and CEO, Effective Oct. 5, 2015 in Replace of John Brooks
Sep 15 15
Joslin Diabetes Center announced a new president and CEO, a week after seeking and getting the resignation its previous CEO of five years. Dr. Peter Amenta has been appointed to the position, effective Oct. 5, 2015. The move effectively comes from within; in addition to serving as dean of the Rutgers Robert Wood Johnson Medical School for eight years, Amenta sat on the Joslin board of trustees for five years. Amenta left the board of trustees earlier 2015 to take on a consultant role and advisor. The move comes exactly a week after John Brooks III resigned from the position. Brooks also had been promoted to the CEO role in 2011 from a member of the organization's board of directors. He reportedly was asked to resign last week, a move that came unexpectedly. Amenta has also worked at University Hospital of New Jersey and was former CEO of the Robert Wood Johnson Medical Group.
Joslin Diabetes Center Announces Executive Changes
Sep 10 15
Joslin Diabetes Center's board of trustees announced that John Brooks stepped down from his role as president, CEO and the board immediately, and was replaced by the organization's chief financial officer and treasurer Eliot Lurier as interim CEO.
David DiFiore Joins Joslin Diabetes Center as Vice President of Clinical Operations
Aug 4 15
Joslin Diabetes Center announced that David DiFiore has joined its executive team as Vice President of Clinical Operations. In his new position, Mr. DiFiore will be responsible for all clinical operations to ensure Joslin continues delivering cutting-edge diabetes care and research. This study was funded by the National Institutes of Health. Prior to joining Joslin, Mr. DiFiore was Director of Finance and Clinical Services for the Department of Pediatrics at Boston Medical Center, overseeing the administration, finance and operations of more than 100 physicians and the pediatric service line, including ambulatory operations, emergency and inpatient services. He previously served as a Clinical Manager at Lahey Hospital & Medical Center, where he directed operational components of Cardiology, Vascular Medicine, Cardiothoracic Surgery, Vascular Surgery, Electrocardiology, Echocardiology and Cardiac Rehabilitation. He is a member of the Medical Group Management Association (MGMA) and Healthcare Financial Management Association (HFMA).
Similar Private Companies By Industry
Recent Private Companies Transactions
|No transactions available in the past 12 months.|